MK-2206 2HCl

Catalog No.S1078

MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM in cell-free assays, respectively; no inhibitory activities against 250 other protein kinases observed. Phase 2.

Price Stock Quantity  
USD 220 In stock
USD 110 In stock
USD 170 In stock
USD 370 In stock
USD 570 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

MK-2206 2HCl Chemical Structure

MK-2206 2HCl Chemical Structure
Molecular Weight: 480.39

Validation & Quality Control

Cited by 179 publications:

18 customer reviews :

Quality Control & MSDS

Related Compound Libraries

MK-2206 2HCl is available in the following compound libraries:

Akt Inhibitors with Unique Features

  • Selective Akt Inhibitor

    CCT128930 AKT2-selective, IC50=6 nM.

  • Most Potent Akt Inhibitor

    AZD5363 Akt1, IC50=3 nM; Akt2, IC50=8 nM; Akt3, IC50=8 nM.

  • Akt Inhibitor in Clinical Trial

    Perifosine (KRX-0401) Phase III fro relapsed and refractory multiple myeloma.

  • Newest Akt Inhibitor

    AZD5363 Potent inhibitor of all isoforms of Akt (Akt1/Akt2/Akt3) with IC50 of 3 nM/8 nM/8 nM, similar to P70S6K/PKA and lower activity towards ROCK1/2.

Product Information

  • Compare Akt Inhibitors
    Compare Akt Products
  • Research Area
  • Inhibition Profile
  • Combination Therapy
    Combination Therapy

Product Description

Biological Activity

Description MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM in cell-free assays, respectively; no inhibitory activities against 250 other protein kinases observed. Phase 2.
Targets Akt1 [1]
(Cell-free assay)
Akt2 [1]
(Cell-free assay)
Akt3 [1]
(Cell-free assay)
IC50 8 nM 12 nM 65 nM
In vitro MK-2206 is an allosteric inhibitor and is activated by the pleckstrin homology domain. MK-2206 inhibits auto-phosphorylation of both Akt T308 and S473. MK-2206 also prevents Akt-mediated phosphorylation of downstream signaling molecules, including TSC2, PRAS40 and ribosomal S6 proteins. [1] MK-2206 inhibits Ras wild-type (WT) cell lines (A431, HCC827, and NCI-H292) more potently when compared to Ras-mutant cell lines (NCI-H358, NCI-H23, NCI-H1299, and Calu-6). MK-2206 also shows synergistic responses in combination with cytotoxic agents such as erlotinib or lapatinib in lung NCI-H460 or ovarian A2780 tumor cells. [2] MK-2206 or siRNA-mediated Akt inhibition strongly activates autophagy in human glioma cells. However, eukaryotic elongation factor-2 (eEF-2) silencing suppresses MK-2206-induced-autophagy, with a promotion of apoptotic cell death. [3]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
NCI-H292M{mzXmN6fG:2b4jpZ{BCe3OjeR?=NIHxWlk{KM7:TR?=MYm3NkBpMWrEUXNQNIrPdFBKdmirYnn0bY9vKG:oIHPlcIwheHKxbHnm[ZJifGmxbh?=NEnqWZEzODV5MUC2PS=>
A431MnHCT4lv[XOnIFHzd4F6M1HHWlUh|ryPM2joS|UhcA>?NUTSRld6TE2VTx?=NX2xRY1TW3WycILld5NmeyC2aHWgd4lodmGuaX7nJI9nKEGtdDDhcoQhTXKtM2O5TlIxPTdzME[5
HepG2NVX1Xlc3S3m2b4TvfIlkKEG|c3H5MWixNEDPxE1?NGjnboYzPCCqM1S0b2ROW09?MkjCV4Vve2m2aYrld{Bz\XOrc4ThcpQh[2WubIOgeI8hfGinIHP5eI91d3irYzDl[oZm[3Rib3[gd49z[W[nbnniNYrmVYhyOjF{MEW5NlU>
Sk-Hep1M3;o[WN6fG:2b4jpZ{BCe3OjeR?=NV\xNZp{OTBizszNMlfxNlQhcA>?M1zufWROW09?M1LvbnNmdnOrdHn6[ZMhemW|aYP0ZY51KGOnbHzzJJRwKHSqZTDjfZRwfG:6aXOg[YZn\WO2IH;mJJNwemGoZX7pZi=>M2PTflIyOjB3OUK1
OCUT1 cells harbored PIK3CA (H1047R+/+)NV\PS3VST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmTxN{DPxE1?NUD0[nlyPSCmNFS1U4FFVVORMkXWTWM2OD1yLkG0JO69VQ>?MkfoNlEzQDl{Nke=
K1 cells harbored PIK3CA (E542K+/+)M2rJdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1jzNVMh|ryPNITDOGE2KGR?MoTSSG1UVw>?MnP1TWM2OD1yLkWyJO69VQ>?NU\SOJFZOjF{OEmyOlc>
FTC133 cells harbored PTEN (allele deletion and R130+)M3PoSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXOzJO69VQ>?M3[z[VUh\A>?NH63XY5FVVORNE\jO5dKSzVyPUCuNVgh|ryPM2TjNlIyOjh7Mk[3
C643 cells harbored HRAS (G13R+/−)NV7RNI15T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33lS|Mh|ryPMX:1JIQ>M{Tpb2ROW09?Mor3TWM2OD1yLkK3JO69VQ>?NF30TpczOTJ6OUK2Oy=>
Hth7 cells harbored NRAS (Q61R+/−)MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2TqblMh|ryPNY\TTZB7PSCmMn\HSG1UVw>?MkfmTWM2OD12LkWg{txONVfBbJFUOjF{OEmyOlc>
TPC1 cells harbored RET/PTC1 rearrangementMkTCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml2wN{DPxE1?M1;ZT|Uh\A>?NGHmOFRFVVORM1v2PGlEPTB;MD61PUDPxE1?NGOzSoQzOTJ6OUK2Oy=>
Hth74NIHiXIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2rxclMh|ryPNFXHXpI2KGR?NY\KWW9VTE2VTx?=M2nx[mlEPTB;Mj6xPUDPxE1?MYeyNVI5QTJ4Nx?=
KAT18NFT6c25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUX0dFZuOyEQvF2=MUm1JIQ>Mlu5SG1UVw>?MUXJR|UxRTRwNkKg{txONIfCRZgzOTJ6OUK2Oy=>
SW1736NITUToZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXexNFAh|ryPNFTTbYM2KGR?MVfEUXNQNH3xTFVKSzVyPUS3MlU3KM7:TR?=M4HZdVIyOjh7Mk[3
WROM2nr[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{DVXFExODBizszNMV[1JIQ>MXvEUXNQMVfJR|UxRjFyMECg{txOMofXNlEzQDl{Nke=
TAD2NV3jVZI1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUWxNFAxKM7:TR?=MmDKOUBlMYXEUXNQMY\JR|UxRjFyMECg{txONIfSN4kzOTJ6OUK2Oy=>
LN229MUHBdI9xfG:|aYOgRZN{[Xl?M1HDXlAvPSEQvF2=M3zhdFYxKGh?MV;EUXNQM3\DbWF2\22nboTzJIFxd3C2b3flcolkKGWoZnXjeJMhd2ZiZ3XmbZRqdmmkMUKyNlA2PzlzNB?=
T98GNHH0fnpCeG:ydH;zbZMhSXO|YYm=MW[wMlUh|ryPMV[2NEBpMV;EUXNQMVfBeYdu\W62czDhdI9xfG:pZX7pZ{Bm\m[nY4TzJI9nKGenZnn0bY5q[g>?MlP3NlIxPTd7MUS=
HC11NYLpcYY1TnWwY4Tpc44hSXO|YYm=NUTDVJB1OTBizszNNWTGcnlpOjRiaB?=M4nmd2ROW09?NH7rNHdKdmirYnn0d{DPui2lYYPlbY4h[W6mIFHEVnAhe3mwdHjld4l{NGfnTZAzOjR{Nk[yNS=>
MOLT-4NGLVfWFEgXSxdH;4bYMhSXO|YYm=MoCxNVAh|ryPMnvOOFghcA>?MVPEUXNQNV7nXVFLUUN3ME2xMlfjiIoQvF2=NWLZPHpEOjJ4MUSyOFM>
CEM-RMlnwR5l1d3SxeHnjJGF{e2G7MUmxNEDPxE1?M17GclQ5KGh?M{XPbmROW09?M1SxW2lEPTB;Mz6z5qCK|ryPNISwO40zOjZzNEK0Ny=>
CEM-SMoezR5l1d3SxeHnjJGF{e2G7NVzYRnduOTBizszNM{HnSlQ5KGh?MWTEUXNQMmPLTWM2OD13LkJihKnPxE1?MUKyNlYyPDJ2Mx?=
MOLT-4MYnGeY5kfGmxbjDBd5NigQ>?NXXFeFM{OTBizszNMXmyOEBpNHrtV4VFVVORNHjKU2lDdG:la4OgZ4VtdHNiaX6geIhmKEdyL1exJJBp[XOnIH;mJJRp\SClZXzsJIN6[2ynMWmyNlYyPDJ2Mx?=
MOLT-4MVzGeY5kfGmxbjDBd5NigQ>?MnXxOQKBkc7:TR?=MVy0JIg>MnjiSG1UVw>?MnfWTY5kemWjc3XzJJRp\SCjbX;1cpQhd2ZiY3zlZZZm\CCOQ{PBM2ItKGFid3XscE1me3SjYnzpd4hm\CCjdYTvdIhi\3libXHyb4VzNVzyfnp2OjJ4MUSyOFM>
CEM-RMXXGeY5kfGmxbjDBd5NigQ>?M3;DeVTjiIoQvF2=MV20JIg>Mk\NSG1UVw>?M{W2N2lv[3KnYYPld{B1cGViYX3veY51KG:oIHPs[YF3\WRiTFO0RU9DNCCjIIflcIwu\XO2YXLsbZNp\WRiYYX0c5Bp[We7IH3hdotmeg>?Mk\xNlI3OTR{NEO=
CEM-SM2HNXWZ2dmO2aX;uJGF{e2G7NH\vVZo16oDLzszNM3XEeFQhcA>?MlrZSG1UVw>?M37VNWlv[3KnYYPld{B1cGViYX3veY51KG:oIHPs[YF3\WRiTFO1RU9DNCCjIIflcIwu\XO2YXLsbZNp\WRiYYX0c5Bp[We7IH3hdotmeg>?NEXCSGczOjZzNEK0Ny=>
HepG2 cellMkO1T4lv[XOnIFHzd4F6M2HvfVIxKM7:TR?=NFHxWlMzPCCqM{KwfWROW09?NFrLbWxFd3ewcnXneYxifGW|IITo[UBxcG:|cHjvdplt[XSrb36gc4YhSUuWNGTjS4EzOzd7N{OxPS=>
HepG2 cellM{jYfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M33zSlMxKM7:TR?=MnK3NlQhcA>?NVrZdlVQTE2VTx?=MV3Jcohq[mm2czDj[YxtKGe{b4f0bC=>MYKyN|c6PzNzOR?=
HepG2 cellMX;BdI9xfG:|aYOgRZN{[Xl?MVGyNEDPxE1?MVuyOEBpMULEUXNQNUX3[o1IUW6mdXPld{Bk\WyuIHHwc5B1d3Orcx?=MlzoNlM4QTd|MUm=
GEONVLxXHNtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnfaOVAxKG6PMnq5O|IhcA>?MVjEUXNQMnXSTY5pcWKrdIOgZ4VtdCCpcn;3eIg>MVGyOFU5OTJ|MR?=
CNE-1NIS5OYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYn3cWcxOTBizszNNUnPVFA2QTZiaB?=M33sUmROW09?M2j1UGlEPTB;Mj65OkDPxE1?NX[zeohMOjV|M{[5NlU>
CNE-2NFXTfnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFiwPW4yOCEQvF2=NGLm[YI6PiCqNHzCO|hFVVORMmXKTWM2OD12LkWzJO69VQ>?NGLDeokzPTN|NkmyOS=>
HONE-1MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV2xNEDPxE1?NVXNZVRZQTZiaB?=MVHEUXNQM1rmXWlEPTB;Mz6zO{DPxE1?NGnPboEzPTN|NkmyOS=>
SUNE-1MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1X1bVExKM7:TR?=M1;GbFk3KGh?NXviV5hlTE2VTx?=NELQRZBKSzVyPUCuOVIh|ryPNFnIWVMzPTN|NkmyOS=>
CNE-2NW\IbIk1TnWwY4Tpc44hSXO|YYm=NVrVfHNEOTBizszNNFLIOnU1QCCqMV;EUXNQNV\uS5FvUW6mdXPld{Bk\WyuIHP5Z4xmKGG{cnXzeEBifCCJMR?=M4DYdlI2OzN4OUK1
HONE-1MUDGeY5kfGmxbjDBd5NigQ>?M37PXFExKM7:TR?=NXvOS|ZtPDhiaB?=MVrEUXNQNFfSfGFKdmS3Y3XzJINmdGxiY4njcIUh[XK{ZYP0JIF1KEdzMkDkNlU{OzZ7MkW=
NEC8Moj4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mnq2TWM2OD1yLkC5OlUyKM7:TR?=M17QcnNCVkeHUh?=
P12-ICHIKAWAMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFTKNmhKSzVyPUCuNVE3OiEQvF2=M1TET3NCVkeHUh?=
MDA-MB-175-VIINX3kdYpGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUDoO2t4UUN3ME2wMlE{PzN6IN88US=>MXLTRW5ITVJ?
AsPC-1M1zpVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2\0VWlEPTB;MD6yNlEzOiEQvF2=NGLZdWxUSU6JRWK=
T47DMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4f0[mlEPTB;MD6yPFI2KM7:TR?=Mo[wV2FPT0WU
HHMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIXlfIdKSzVyPUCuN|AzQDNizszNNHTvUHZUSU6JRWK=
MOLT-16MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWfnWZBRUUN3ME2wMlMxOzJizszNMWHTRW5ITVJ?
ES5MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVjJR|UxRTBwM{S0OVUh|ryPNXLWdIVCW0GQR1XS
RS4-11Mmj1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXS2TGNGUUN3ME2wMlM1PjFizszNNEKwcXBUSU6JRWK=
KARPAS-45NYGzTWdST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXvPSmJ1UUN3ME2wMlM4OzJzIN88US=>NEjER5RUSU6JRWK=
NCI-H720NGrrWpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVH0ZlZrUUN3ME2wMlM4Pjd7IN88US=>NHLZR2RUSU6JRWK=
H9NYHDZXV3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1zL[mlEPTB;MD6zPFg5OyEQvF2=Mme4V2FPT0WU
EFM-19M{LX[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX3FV2lsUUN3ME2wMlQ1ODFizszNM1rPd3NCVkeHUh?=
SBC-1M2PqbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXn0VmpsUUN3ME2wMlQ1ODN3IN88US=>NIGyWHZUSU6JRWK=
A4-FukMYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml70TWM2OD1yLkS2PFY5KM7:TR?=MmrQV2FPT0WU
NCI-H1563Mm\PS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkPHTWM2OD1yLkS4NVg6KM7:TR?=MnfkV2FPT0WU
HCC1419M170NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH3sXZNKSzVyPUCuOFg5QTJizszNNIfy[pVUSU6JRWK=
H-EMC-SSNUK5dlQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlrHTWM2OD1yLkS5PVM6KM7:TR?=M2LCZ3NCVkeHUh?=
BHT-101NFT6eppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYjTTlB7UUN3ME2wMlUzQTZzIN88US=>MVnTRW5ITVJ?
IGROV-1NF\ON4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnTBTWM2OD1yLkW1NlQ6KM7:TR?=M4nsdnNCVkeHUh?=
HGC-27NXPmRWprT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEXKUolKSzVyPUCuOVY4QDNizszNMl[0V2FPT0WU
MDA-MB-361M1nue2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MonvTWM2OD1yLkW3O|YyKM7:TR?=MUjTRW5ITVJ?
KE-37M3e0cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NELETIxKSzVyPUCuOVgzPiEQvF2=NFHhfJNUSU6JRWK=
HCC70M2TwRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{DjfGlEPTB;MD61PVgzPyEQvF2=MnKyV2FPT0WU
LNCaP-Clone-FGCM3m1NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFfT[lRKSzVyPUCuOlExPDhizszNMlXsV2FPT0WU
HAL-01NVr4e3Y3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV3t[XQ3UUN3ME2wMlYzOTNizszNNFyzZnNUSU6JRWK=
HTM4LlWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWTReJlXUUN3ME2wMlY{OjN7IN88US=>NXHoVFJOW0GQR1XS
MDA-MB-415MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYXxNGFZUUN3ME2wMlY{PjJ4IN88US=>M2fmZ3NCVkeHUh?=
NOS-1NWfKdVJWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGXSd2lKSzVyPUCuOlM4OjNizszNM4\hOXNCVkeHUh?=
DU-145NIPJbVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFu0UVJKSzVyPUCuOlQ4PDVizszNNETpSXJUSU6JRWK=
OCUB-MM37kOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWHFeFhVUUN3ME2wMlcxQTZ4IN88US=>MWrTRW5ITVJ?
VA-ES-BJM32xe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M13GdWlEPTB;MD63N|AzPSEQvF2=MV;TRW5ITVJ?
J-RT3-T3-5NFrYVmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWrJR|UxRTBwN{S0NFMh|ryPMn7vV2FPT0WU
MOLT-4MmeyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rqbGlEPTB;MD64NFU5OiEQvF2=MUTTRW5ITVJ?
NB7MkDrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIn5cGZKSzVyPUCuPFI1OTFizszNM1LFN3NCVkeHUh?=
L-363NEnvb|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3XhUWlEPTB;MD64N|Q1OiEQvF2=MUXTRW5ITVJ?
NKM-1NF\zWoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEDmWJlKSzVyPUCuPFYzPTNizszNMoHSV2FPT0WU
HOP-92NXLON4FXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1nzdWlEPTB;MD64O|IzOyEQvF2=MXnTRW5ITVJ?
OAW-42NF;jZ5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHLrXW9KSzVyPUCuPFg4OiEQvF2=NGXVW29USU6JRWK=
HuO9NYXDRWlTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3PNXGlEPTB;MD65Nlc2OSEQvF2=M2Ln[HNCVkeHUh?=
MFE-280M3\RXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mny2TWM2OD1yLkm2OFY2KM7:TR?=Mm\KV2FPT0WU
EM-2NWHyPW1pT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NITiPXRKSzVyPUCuPVc6OzlizszNNHr3eZhUSU6JRWK=
NCI-H520Mln5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYXlW5ZIUUN3ME2wMlk5PTl{IN88US=>M4\xVnNCVkeHUh?=
LB2241-RCCNH7LfGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2nibWlEPTB;MD65PVc{PCEQvF2=NWnqNnNUW0GQR1XS
SK-NEP-1MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTFwMUS0PFUh|ryPNYS3e3ltW0GQR1XS
LXF-289NWTOfFVsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3XuWmlEPTB;MT6xO|E2PiEQvF2=MnHzV2FPT0WU
EPLC-272HMmnuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF3JfIZKSzVyPUGuNVczPTZizszNNUWy[4ZYW0GQR1XS
COLO-684M3fBXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTFwMkO3NlUh|ryPNVnHUoR7W0GQR1XS
ES1NF:2UJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF3VdFNKSzVyPUGuNlQxPjVizszNNYHLd5IxW0GQR1XS
DOHH-2MnrmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M37CXmlEPTB;MT6yPFIxOyEQvF2=NEDJSpBUSU6JRWK=
CTB-1NIriVFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmW4TWM2OD1zLkK4PVkh|ryPMXXTRW5ITVJ?
G-401NYjaT2NLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIrRZZdKSzVyPUGuNlk4QTVizszNMl;KV2FPT0WU
LoVoMlTtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXftPJJ[UUN3ME2xMlMzPTN2IN88US=>MmH5V2FPT0WU
Ramos-2G6-4C10NGntW41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVXJR|UxRTFwM{O3NFEh|ryPMVHTRW5ITVJ?
MFM-223NXOxSXFHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1iyWWlEPTB;MT6zOFQ3OSEQvF2=M3v6e3NCVkeHUh?=
PA-1MmKwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYTJR|UxRTFwM{WyOlUh|ryPM2jmc3NCVkeHUh?=
697MkW1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mle2TWM2OD1zLkO3OlE3KM7:TR?=MUDTRW5ITVJ?
QIMR-WILNFrm[5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4n2emlEPTB;MT60PVEyPiEQvF2=NUP4OmR7W0GQR1XS
HOSNYnXR5dVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4DjfWlEPTB;MT60PVU2QCEQvF2=MY\TRW5ITVJ?
DMS-273NY\lXWR3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{jONWlEPTB;MT61NVk2QSEQvF2=M4XE[3NCVkeHUh?=
ME-180MlzuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlLJTWM2OD1zLkW2PFkyKM7:TR?=MX3TRW5ITVJ?
HCC2218NU\mN2V3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHfOeJlKSzVyPUGuOlgzOjVizszNNGjtSYhUSU6JRWK=
CAL-54Mk\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX\JR|UxRTFwN{GyOFIh|ryPM3u4TXNCVkeHUh?=
OMC-1NWPoU5J3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHznPHFKSzVyPUGuO|Q3PzdizszNM3T5eHNCVkeHUh?=
COR-L105NFrHR4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoDyTWM2OD1zLke5O|M4KM7:TR?=MonQV2FPT0WU
BV-173MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWrJR|UxRTFwOEGwO|Qh|ryPMoq2V2FPT0WU
RKOMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3LmfWlEPTB;MT64O|ExOSEQvF2=NVuwVm5DW0GQR1XS
SNU-387M2\yR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTFwOEi0NFYh|ryPM3HubXNCVkeHUh?=
SW1088M1\tfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MomzTWM2OD1zLkm0OlA3KM7:TR?=MWHTRW5ITVJ?
Hs-578-TMY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmXETWM2OD1{LkGxOFM{KM7:TR?=NF36XoJUSU6JRWK=
OC-314NGrCfIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEfSfo9KSzVyPUKuNVUxQDZizszNMni4V2FPT0WU
RMG-IM3nPV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWnJR|UxRTJwMU[zPVgh|ryPNH\KZ2hUSU6JRWK=
NCI-H1395M{TTb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVzpUmRWUUN3ME2yMlE5ODlzIN88US=>MnG3V2FPT0WU
GAMGNVi3TFZTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEf3b3pKSzVyPUKuNlM5PDVizszNMY\TRW5ITVJ?
LB1047-RCCM3PMTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MofzTWM2OD1{LkK0N|E4KM7:TR?=NWj6cpBKW0GQR1XS
MN-60MoewS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoDJTWM2OD1{LkK5PVI{KM7:TR?=NGjBdYdUSU6JRWK=
OAW-28M3:0cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NITYeJNKSzVyPUKuNlk6PTFizszNMlXCV2FPT0WU
NCI-H2228NGLTNFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXTJR|UxRTJwM{G1OVIh|ryPM{TWTnNCVkeHUh?=
ABC-1NV7kfZg2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33D[2lEPTB;Mj6zN|I2OyEQvF2=MmTHV2FPT0WU
LS-513NX;FdWViT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVzudVdiUUN3ME2yMlM{PDh2IN88US=>M2TK[HNCVkeHUh?=
KS-1MoHES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWTs[JVjUUN3ME2yMlM5OTlzIN88US=>NUDETG5QW0GQR1XS
NB69M2fKfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmHaTWM2OD1{LkO4PVg{KM7:TR?=M1\EWHNCVkeHUh?=
VM-CUB-1Ml3WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYnJR|UxRTJwM{mwPFMh|ryPMXLTRW5ITVJ?
D-423MGM1X4TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYjJR|UxRTJwNEGwOFQh|ryPMoHSV2FPT0WU
EW-18M2LZO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUDJR|UxRTJwNEG5N|kh|ryPM3noVXNCVkeHUh?=
YH-13NHP5cnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF[wZXlKSzVyPUKuOFYyPTNizszNNWrrRnB{W0GQR1XS
T-24MkDqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUS1emsyUUN3ME2yMlQ4QDhzIN88US=>MXrTRW5ITVJ?
ES8M1PBOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVLWdZNPUUN3ME2yMlQ6Ojh5IN88US=>MUDTRW5ITVJ?
ES3NWTaVYNtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnjITWM2OD1{LkS5O|U6KM7:TR?=NYe1WpMxW0GQR1XS
RXF393M1nkT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEXwc3pKSzVyPUKuOlA1QDdizszNNWi5WlVnW0GQR1XS
RPMI-8226MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1LNSWlEPTB;Mj62Nlk2OyEQvF2=NUTXZYhnW0GQR1XS
AGSM2rzdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH;3fnNKSzVyPUKuO|IyOzdizszNNGjxS5NUSU6JRWK=
HCC1395M1vxV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2C2NWlEPTB;Mj63OVE5PyEQvF2=NVXwR|JoW0GQR1XS
MV-4-11NWH2NXZFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGfXdmxKSzVyPUKuO|UzPjZizszNM1TVOXNCVkeHUh?=
A204M4K5Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFfxR2hKSzVyPUKuPFM5PzJizszNNEP6fGlUSU6JRWK=
MCF7Mn;yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXHJR|UxRTJwOE[xNVch|ryPNUjqVHZlW0GQR1XS
SNU-423MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXrJR|UxRTJwOEmyOFIh|ryPNHTYdZlUSU6JRWK=
NCI-H1048MofxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTJwOU[4OlUh|ryPMkTnV2FPT0WU
GR-STM{jOSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF3Hc4dKSzVyPUOuNFQ3OTFizszNMkDWV2FPT0WU
EoL-1-NHH4Z4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4rvO2lEPTB;Mz6wO|A2QCEQvF2=Mom0V2FPT0WU
HuH-7NYP0WnJpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX;JR|UxRTNwMEm0OlQh|ryPMnKwV2FPT0WU
OS-RC-2NFPYd2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX\JR|UxRTNwMUGxPUDPxE1?MojOV2FPT0WU
EW-3MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NE\B[XZKSzVyPUOuNVk2OjlizszNM4\2Z3NCVkeHUh?=
NCI-H747NGfGeFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVvJR|UxRTNwMkC2PVQh|ryPMWXTRW5ITVJ?
EW-16MnXYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGXjNllKSzVyPUOuNlE5PzlizszNNWjhUGR5W0GQR1XS
DOKNULESG1RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGS4VmlKSzVyPUOuNlI5PTlizszNNE\GT5FUSU6JRWK=
HCC2157MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnvQTWM2OD1|LkO4NVc6KM7:TR?=M33XNXNCVkeHUh?=
OVCAR-3MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVu5dolPUUN3ME2zMlQxPzh4IN88US=>NFfvcWhUSU6JRWK=
NCI-H1623M3HkcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml;zTWM2OD1|LkSxNlI1KM7:TR?=M2Wxb3NCVkeHUh?=
H4M1LDWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTNwNEW2NlYh|ryPM4e1NHNCVkeHUh?=
SW1710MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTNwNE[2O|gh|ryPM3HIfHNCVkeHUh?=
RT-112MnnMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUn1dXV{UUN3ME2zMlUzOzh6IN88US=>MUHTRW5ITVJ?
DMS-114NVH0fWhjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEjrbZZKSzVyPUOuOlIzPzhizszNNHfBbG1USU6JRWK=
AN3-CANVv3Z5N1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\WV2M1UUN3ME2zMlYzPDV4IN88US=>MX;TRW5ITVJ?
KNS-62M4HPZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3XKU2lEPTB;Mz62N|M{QCEQvF2=M2i3NXNCVkeHUh?=
SJRH30NVG5fG9nT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M13BdWlEPTB;Mz62PVEzOiEQvF2=MVvTRW5ITVJ?
G-402MmH5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUjJR|UxRTNwN{C3NVEh|ryPM1vvcHNCVkeHUh?=
MHH-PREB-1MmLkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml[3TWM2OD1|LkeyNFM5KM7:TR?=NH;UdoZUSU6JRWK=
P30-OHKNHjPXXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUPIUmtSUUN3ME2zMlgxQTd4IN88US=>MXfTRW5ITVJ?
RVH-421M1zMWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkDnTWM2OD1|LkixO|g5KM7:TR?=NVLX[JFCW0GQR1XS
LU-134-AMo\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHr4c2pKSzVyPUOuPFg1OjhizszNM{SzRXNCVkeHUh?=
ECC10NVTOc4w1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWHJR|UxRTNwOUO2NlIh|ryPNHXwS4NUSU6JRWK=
TGWNGLvenpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWHrTlVnUUN3ME20MlAzOzB3IN88US=>MmPxV2FPT0WU
MLMANYH2UYhmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlO0TWM2OD12LkCyPVY3KM7:TR?=M2TvNHNCVkeHUh?=
SCC-25NW\Yd5B3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYPndHVJUUN3ME20MlA3PTZ4IN88US=>MWTTRW5ITVJ?
TYK-nuNVXXcYh1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXLtc41kUUN3ME20MlA6PTN2IN88US=>MUPTRW5ITVJ?
LAMA-84M3LlUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFO3bYZKSzVyPUSuNVQyQTFizszNMoHhV2FPT0WU
Calu-3NUnqeItUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVzJR|UxRTRwMkS0NVYh|ryPM3XmWXNCVkeHUh?=
NCI-H460NYPJ[3hxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH\tXoZKSzVyPUSuNlY1PDNizszNMoTXV2FPT0WU
EGI-1MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV\JR|UxRTRwM{e3O|gh|ryPNF7JbmVUSU6JRWK=
NCI-H292M4HNfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWfJR|UxRTRwM{ixOFYh|ryPNHf2bWZUSU6JRWK=
HCE-TMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;KTWM2OD12LkSxOVc6KM7:TR?=NETYVVhUSU6JRWK=
EW-11NELNcpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HiTGlEPTB;ND60NVg{QCEQvF2=MorQV2FPT0WU
ATN-1MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYHJR|UxRTRwNESzNFQh|ryPM1;IXHNCVkeHUh?=
NB5Mm\BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1[4WGlEPTB;ND61N|Y6PyEQvF2=NUjPcFZxW0GQR1XS
KLEMnrtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGXaeXFKSzVyPUSuO|AyQThizszNMlHrV2FPT0WU
CAL-39NWHkPVRrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHXkWXFKSzVyPUSuO|IyPDZizszNM3[3eXNCVkeHUh?=
TI-73MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn\PTWM2OD12LkiwOlA6KM7:TR?=MoPqV2FPT0WU
HO-1-N-1M1nDO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTRwOUSyJO69VQ>?MX7TRW5ITVJ?
786-0MorJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2rTfGlEPTB;ND65OFY4OyEQvF2=M{\Oe3NCVkeHUh?=
SK-N-DZM4r1VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH3pTmNKSzVyPUSuPVYyPDJizszNM4rpV3NCVkeHUh?=
NCI-H446MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFiweHFKSzVyPUWuNlAxODlizszNMnfTV2FPT0WU
ETK-1MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWDXR4ZiUUN3ME21MlIyOTZ3IN88US=>NIHQdo5USU6JRWK=
BT-20M{ni[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{ixUWlEPTB;NT6yNVM2OyEQvF2=NFHlWFFUSU6JRWK=
MEL-HOM13ISmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmXFTWM2OD13LkO3N|M3KM7:TR?=M3XibHNCVkeHUh?=
CAL-27MkGxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTVwNE[zN|kh|ryPM1nXRnNCVkeHUh?=
SW872Ml;mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MULJR|UxRTVwNUm0Nlgh|ryPM3TiTHNCVkeHUh?=
RPMI-2650MljUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXy1eFVtUUN3ME21MlY3OTl7IN88US=>MljjV2FPT0WU
PFSK-1NFH3Uo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVjJR|UxRTVwN{K3N|Ih|ryPMYnTRW5ITVJ?
SF295MnHrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmG5TWM2OD13LkiwOlM{KM7:TR?=Ml;xV2FPT0WU
BeckerM3jVU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmrFTWM2OD13Lki2OFczKM7:TR?=MX3TRW5ITVJ?
Saos-2MkL4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4jRWWlEPTB;NT64OlU{KM7:TR?=MmOwV2FPT0WU
SK-OV-3NFK2fXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYPJR|UxRTVwOUm4NVYh|ryPNXruR5dxW0GQR1XS
VMRC-RCZNFH1VGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH:5XXlKSzVyPU[uNFg4PzNizszNMl\oV2FPT0WU
EW-22NHfU[WRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NELYc3FKSzVyPU[uNVk3PDlizszNNUDLbZhwW0GQR1XS
BT-474NHTrVWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXnVUpZLUUN3ME22MlI{OyEQvF2=MWnTRW5ITVJ?
BFTC-909MnLiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NG\WU3hKSzVyPU[uN|A{PDVizszNMXrTRW5ITVJ?
NB12MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2ryN2lEPTB;Nj6zPVA4OSEQvF2=NGXF[GlUSU6JRWK=
D-263MGM3HTOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTZwNEWxOlkh|ryPM{LESHNCVkeHUh?=
SNB75NFPpRnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoXkTWM2OD14Lk[wNVQ{KM7:TR?=MoTkV2FPT0WU
A704M3HGSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWPRcnN1UUN3ME22MlY{ODZizszNNFHmO5hUSU6JRWK=
NCI-H1693M2fCeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mm[4TWM2OD14Lk[zOlA1KM7:TR?=NFXzTXVUSU6JRWK=
LN-405MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHX3SFhKSzVyPU[uO|k3PzJizszNNHTjNoNUSU6JRWK=
CHL-1NIHucXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVfJR|UxRTZwOECwO|kh|ryPM3zueHNCVkeHUh?=
A498NIP3W2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF\UelJKSzVyPU[uPFE6PjFizszNNXTlPGRCW0GQR1XS
TE-12MkDVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mor3TWM2OD14LkizPFE4KM7:TR?=NELXfJlUSU6JRWK=
TE-6NG\ScJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NW\IZmFrUUN3ME22Mlk{ODN6IN88US=>MWLTRW5ITVJ?
AU565M{DLRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{ez[WlEPTB;Nj65Olk2PyEQvF2=MnfEV2FPT0WU
RDNFTvclhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NELh[plKSzVyPU[uPVgzQDRizszNMVrTRW5ITVJ?
SW1463NGHiUWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2HxNWlEPTB;Nz6xNVE3QCEQvF2=NYC2V3RYW0GQR1XS
LU-99AMo\XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlO4TWM2OD15LkG0N|IzKM7:TR?=MXrTRW5ITVJ?
NCI-H28NF;3[5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVzJR|UxRTdwMkmyOEDPxE1?MX;TRW5ITVJ?
MC-IXCMkTXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mlz3TWM2OD15LkS4OVc3KM7:TR?=NGDTc2lUSU6JRWK=
GP5dMnzjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUG3[ZR4UUN3ME23MlQ5PzZ2IN88US=>M3nOXHNCVkeHUh?=
GB-1MmTXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYXJR|UxRTdwNUS4NFQh|ryPM2HxV3NCVkeHUh?=
CAL-33NVPDeHJKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoTRTWM2OD15Lk[2NlM{KM7:TR?=MkLQV2FPT0WU
MSTO-211HMkjaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFrUVZVKSzVyPUeuOlc{OzZizszNMojnV2FPT0WU
TE-5NITrU2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF\mOVdKSzVyPUeuO|k{OzRizszNMnrjV2FPT0WU
D-566MGMlLZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVXJR|UxRThwMES0Nlkh|ryPMn7BV2FPT0WU
JVM-3Ml7VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkLVTWM2OD16LkG1NlY5KM7:TR?=NXfob4RVW0GQR1XS
T98GMULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEH0WW5KSzVyPUiuNVgxPjdizszNM3T2bXNCVkeHUh?=
HCC1954NWfrUXBiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlPCTWM2OD16LkS1NVA1KM7:TR?=Mki2V2FPT0WU
SF126MlTRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2PEZWlEPTB;OD60OVk{PiEQvF2=NI\xbWtUSU6JRWK=
LB996-RCCNInwTIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFfhUW1KSzVyPUiuOVMzPTdizszNM3;4UXNCVkeHUh?=
SKG-IIIaMV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYLJR|UxRThwNkOwOlkh|ryPMXrTRW5ITVJ?
NCI-SNU-1NULHeGkyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3vqd2lEPTB;OD62OFY1OyEQvF2=NIi5[GhUSU6JRWK=
LB771-HNCNFfIUJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4HJN2lEPTB;OD62OFY6PiEQvF2=M1f6THNCVkeHUh?=
SCC-4NH6zenFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mm\ETWM2OD16Lk[4NlE6KM7:TR?=MV;TRW5ITVJ?
CAMA-1MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmDYTWM2OD16Lke3NVQ3KM7:TR?=MmDaV2FPT0WU
D-502MGM2HCZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NI[1e5lKSzVyPUiuO|g3OjlizszNNV31bXRPW0GQR1XS
ESS-1NVvFR|ZmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHfE[3ZKSzVyPUiuPFg4ODRizszNNX3COJEyW0GQR1XS
HEC-1NYjD[GhsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRThwOEm4OlYh|ryPM1zGT3NCVkeHUh?=
NB10NFPicmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmT2TWM2OD17LkCyNlI1KM7:TR?=M3LFc3NCVkeHUh?=
8505CMVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4XLW2lEPTB;OT6wOFI{OiEQvF2=MXXTRW5ITVJ?
EFO-27M{HHWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmToTWM2OD17LkG2OFEzKM7:TR?=NWL6W4RxW0GQR1XS
HNNUTmOWhST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXrFd2d2UUN3ME25MlE3PjJ6IN88US=>M1GwbnNCVkeHUh?=
DSH1M4P3VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFv2[ZZKSzVyPUmuNlA5PyEQvF2=NVrod49yW0GQR1XS
NBsusSRNXrZU|JlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYnFdWcyUUN3ME25MlI4PDB{IN88US=>NV[zfooxW0GQR1XS
LS-123NVjFWoc5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYrF[nZqUUN3ME25MlMyPzZzIN88US=>NGXOUWhUSU6JRWK=
SHP-77MmL6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWO4b2xjUUN3ME25MlM6QTN3IN88US=>NEHZZmNUSU6JRWK=
ACNNE\vb5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MW\JR|UxRTlwNUOyO|ch|ryPMki0V2FPT0WU
U251NG\UeY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIDmUZJKSzVyPUmuOlU2PDRizszNMoPZV2FPT0WU
A431M4X0Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWjNVWllUUN3ME25MlgxOjN6IN88US=>MVXTRW5ITVJ?
5637M3jlVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1W1V2lEPTB;OT64OFk5PCEQvF2=NEfkbpFUSU6JRWK=
MDA-MB-157NFznNVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXvFPGl3UUN3ME25MlkzQDd6IN88US=>MWTTRW5ITVJ?
A101DMV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4DDdWlEPTB;OT65PVk4PCEQvF2=NHPyVnJUSU6JRWK=
YKG-1NYP0eGFmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXRTWM2OD1zMD6yNFA3KM7:TR?=NWH1XldJW0GQR1XS
LAN-6M1Hz[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV\pZ2dwUUN3ME2xNE4zOTZ2IN88US=>MVXTRW5ITVJ?
OVCAR-5NVP0TlgyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoK4TWM2OD1zMD6yOFM{KM7:TR?=NWfCTYduW0GQR1XS
A549NYW0S5RZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGTHZ|JKSzVyPUGwMlM6PzNizszNNVrPZWFjW0GQR1XS
no-11M2DWS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NULPZZViUUN3ME2xNE41OzV|IN88US=>NV3NToFkW0GQR1XS
SF539M2jDbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXHJR|UxRTFyLkmwOFEh|ryPNITWS4NUSU6JRWK=
A388NVXrfHFDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NULMT4h4UUN3ME2xNU4{QDl5IN88US=>NYjhd3pvW0GQR1XS
DELMWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWnWSlhpUUN3ME2xNU41OjRizszNMV3TRW5ITVJ?
SW954NWHnblJoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4rmcGlEPTB;MUGuOFY3QCEQvF2=NVvKZWJVW0GQR1XS
TK10MnPNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEPSZnBKSzVyPUGxMlUzPzFizszNNVnVVWlOW0GQR1XS
SW756NGWyd2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVLJR|UxRTFzLkWyPVQh|ryPNFXmXZVUSU6JRWK=
PC-3M1XOdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2H3WGlEPTB;MUGuOVc3PCEQvF2=NIrLRllUSU6JRWK=
ONS-76MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3jrc2lEPTB;MUGuOlM3KM7:TR?=Ml\zV2FPT0WU
A427NHiwWZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEO0R4pKSzVyPUGxMlcxQTNizszNNFi4U5JUSU6JRWK=
MEG-01MnnUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mmf4TWM2OD1zMT63OVA6KM7:TR?=NU\M[Zl5W0GQR1XS
BB30-HNCNHuxdWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTFzLke5PFIh|ryPNH3xU25USU6JRWK=
NCI-H1299M1zGT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2jCXGlEPTB;MUGuPFA6OyEQvF2=NFjGNndUSU6JRWK=
GCTMmDES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWTJR|UxRTFzLkiyNlgh|ryPNEHJfGZUSU6JRWK=
D-247MGMk\US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoPSTWM2OD1zMT65OlY{KM7:TR?=M{nmUXNCVkeHUh?=
CFPAC-1MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkPSTWM2OD1zMT65O|gzKM7:TR?=M2jT[XNCVkeHUh?=
EKVXNYm0d4JlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mnq2TWM2OD1zMj6wN|E{KM7:TR?=MXrTRW5ITVJ?
CAL-51M2e1WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{LFUWlEPTB;MUKuNFcyPiEQvF2=NUXRbWpuW0GQR1XS
BB49-HNCNGr4[ldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWLJR|UxRTF{LkGxO|ch|ryPMUXTRW5ITVJ?
RPMI-7951M3q4V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NILBVnlKSzVyPUGyMlE5PTRizszNNXr1ZnRrW0GQR1XS
RH-1MmXkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2TrNGlEPTB;MUKuNlE5PCEQvF2=MYPTRW5ITVJ?
BCPAPM4LhNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIixOJpKSzVyPUGyMlQ4PDlizszNNIXVb3ZUSU6JRWK=
GCIYNY\s[VhXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3nWd2lEPTB;MUKuOVIxQSEQvF2=M4XBd3NCVkeHUh?=
KNS-81-FDM{PYT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{ezS2lEPTB;MUKuOVg3QSEQvF2=NHGz[YJUSU6JRWK=
KYSE-140MoLXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MonQTWM2OD1zMj64OVk2KM7:TR?=NWXCSFlRW0GQR1XS
Ca-SkiMkLqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1;JfmlEPTB;MUKuPVA1OSEQvF2=NWHYcWw5W0GQR1XS
TGBC1TKBMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVXJR|UxRTF{LkmxNVUh|ryPNH3PNpVUSU6JRWK=
HCC1187NGPHTlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{n6[WlEPTB;MUOuNVkyOiEQvF2=NHW4bplUSU6JRWK=
SJSA-1NEC2O2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{jtVmlEPTB;MUOuNlMzPyEQvF2=M1y4NHNCVkeHUh?=
CTV-1MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXvJR|UxRTF|LkO0OUDPxE1?MWDTRW5ITVJ?
WM-115M{TTVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXjJR|UxRTF|Lk[0PFMh|ryPM{fReHNCVkeHUh?=
CHP-212M2nkZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\aflhMUUN3ME2xN{46PzN7IN88US=>NXPwNm9rW0GQR1XS
SCC-15MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFrVUFRKSzVyPUGzMlk4PzVizszNNX7MXVN2W0GQR1XS
BPH-1MnuyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mk\rTWM2OD1zND6xOlY1KM7:TR?=MVTTRW5ITVJ?
SW780M{XZcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3TIeWlEPTB;MUSuOVAzPSEQvF2=M3TiVXNCVkeHUh?=
NCI-H2291NV20e2NMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2HzXmlEPTB;MUSuOVg4QCEQvF2=M3rZ[3NCVkeHUh?=
JEG-3MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlywTWM2OD1zND62N|I3KM7:TR?=NWLPRpFEW0GQR1XS
CAL-120MoOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYq1OmtVUUN3ME2xOE44ODJ5IN88US=>Mn[5V2FPT0WU
NCI-H23NXzZOHZ2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1fUUGlEPTB;MUSuO|k6PyEQvF2=M4fQO3NCVkeHUh?=
MS-1M3H6OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkTZTWM2OD1zND65OlEyKM7:TR?=M1jvPXNCVkeHUh?=
PC-14MnHhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1\TOWlEPTB;MUSuPVY2PCEQvF2=NXXib|FQW0GQR1XS
D-283MEDM3nN[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFrZdWtKSzVyPUG1MlAyOTFizszNMWHTRW5ITVJ?
OE19NI\mTJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmTMTWM2OD1zNT6xOVQyKM7:TR?=NETxS5ZUSU6JRWK=
CAS-1M1T6bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTF3LkSxPFQh|ryPNVi1O2tzW0GQR1XS
NCI-H727MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4TyRmlEPTB;MUWuOFIzOSEQvF2=MWjTRW5ITVJ?
SiHaMWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWH2fJRzUUN3ME2xOU44PTl2IN88US=>M{XWVXNCVkeHUh?=
BFTC-905NWGw[Y9VT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4q0W2lEPTB;MUWuO|Y6PCEQvF2=M4HxNHNCVkeHUh?=
MDA-MB-453NIC5[WdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmWyTWM2OD1zNj6xOlQzKM7:TR?=NILhNlFUSU6JRWK=
HuP-T3NEjTZ2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlrFTWM2OD1zNj62N|c{KM7:TR?=NEXUSVhUSU6JRWK=
SK-LU-1M4P2Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4n3XmlEPTB;MU[uOlk2PiEQvF2=NELUb41USU6JRWK=
Detroit562NGTVZ|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFnTPIZKSzVyPUG2Mlc{OThizszNMofzV2FPT0WU
HCC1569MmS2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHPaPHNKSzVyPUG2Mlg{OzdizszNNVP2OGh7W0GQR1XS
SK-MES-1M2L1OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHeyb3hKSzVyPUG2Mlg1OTlizszNNXLSPXlLW0GQR1XS
BB65-RCCMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUPuVYJpUUN3ME2xO{4xPDd7IN88US=>NWriU2lGW0GQR1XS
LOXIMVINXTIRXBVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmG0TWM2OD1zNz6wO|A4KM7:TR?=NYK4PFFEW0GQR1XS
SW1783NXnvNXNwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYjrPItjUUN3ME2xO{4yOjhizszNMnHjV2FPT0WU
NH-12MmPHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVrNPZl2UUN3ME2xO{4{OzB|IN88US=>MYnTRW5ITVJ?
UACC-257Mof1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1\yemlEPTB;MUeuOVUyOiEQvF2=M3\rZ3NCVkeHUh?=
KOSC-2MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXvnR5VmUUN3ME2xO{43PzV5IN88US=>NV7LWHpiW0GQR1XS
KG-1NHnx[pBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYrNbYtFUUN3ME2xO{43QTN5IN88US=>MVXTRW5ITVJ?
M059JMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MY\JR|UxRTF5LkewN{DPxE1?MkS3V2FPT0WU
MHH-NB-11NV\0Z2NzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1v2b2lEPTB;MUeuPVY4OyEQvF2=Mm\EV2FPT0WU
EW-1M37XbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYjJR|UxRTF6LkGzPFIh|ryPNXqzT3pUW0GQR1XS
CAL-85-1NHz1dndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWnmRZZ1UUN3ME2xPE4zOzV5IN88US=>MV\TRW5ITVJ?
639-VM1;QUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUnJR|UxRTF6LkOzOVQh|ryPM4rWSHNCVkeHUh?=
C32MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1\z[GlEPTB;MUiuOFczPyEQvF2=MVHTRW5ITVJ?
KM-H2M2f5TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlX0TWM2OD1zOD61NlMzKM7:TR?=MlXiV2FPT0WU
A253MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnvRTWM2OD1zOD63Nlg3KM7:TR?=NWWy[3BlW0GQR1XS
NCI-N87M1u2SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV7JR|UxRTF6LkmwNFgh|ryPMlfIV2FPT0WU
8-MG-BAM2DOd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHrW[GRKSzVyPUG5MlA3PDZizszNM3;OSnNCVkeHUh?=
GI-ME-NNI\rNnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVzD[W1PUUN3ME2xPU4yPTR4IN88US=>NUe0[pJKW0GQR1XS
8305CMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH7WdJFKSzVyPUG5MlIzQDZizszNMnj0V2FPT0WU
TE-8MlLkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnTLTWM2OD1zOT6zNFI1KM7:TR?=NUW1ZoNIW0GQR1XS
KYSE-270NYnKe4cyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{XiPWlEPTB;MkCuNFIyPyEQvF2=Mlj0V2FPT0WU
HL-60NY\Zco5RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXLVUopEUUN3ME2yNE4xQTRzIN88US=>MnLFV2FPT0WU
Mo-TMmXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3vXOGlEPTB;MkCuNVY3PSEQvF2=M{O1[nNCVkeHUh?=
NCI-H1355NVnRcWMzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHvZeZBKSzVyPUKwMlM{PzRizszNNIjPRplUSU6JRWK=
HT-1080NWrmVlQ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHfKclNKSzVyPUKwMlU1QTdizszNMYDTRW5ITVJ?
MIA-PaCa-2NX\WXY81T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{LheGlEPTB;MkCuOlg5OyEQvF2=NYP4[4lxW0GQR1XS
NCI-H441M{nWe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGfQfI1KSzVyPUKwMlc{PzlizszNM{XUTHNCVkeHUh?=
LCLC-97TM1MlPKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYLleHRDUUN3ME2yNE45OTN2IN88US=>MWnTRW5ITVJ?
HT-3M3fu[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mm\2TWM2OD1{MT61OlMyKM7:TR?=NHK2SIlUSU6JRWK=
22RV1NXXPNIV7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXHMWWJSUUN3ME2yNU42Pjh3IN88US=>NIXtRWZUSU6JRWK=
LK-2MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVnJR|UxRTJzLkW5OVMh|ryPMmjxV2FPT0WU
CW-2NITIW3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnfqTWM2OD1{MT62NFY6KM7:TR?=NECwPGZUSU6JRWK=
KYSE-510MluzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnnYTWM2OD1{MT62NFk2KM7:TR?=Mn3KV2FPT0WU
CGTH-W-1MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1TGNWlEPTB;MkGuO|E3PiEQvF2=NGTQZm1USU6JRWK=
NCI-H661NWjBdmMxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{j3fWlEPTB;MkKuNFM1KM7:TR?=Ml[5V2FPT0WU
KU-19-19M4XDcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MofzTWM2OD1{Mj6xOlk4KM7:TR?=M1HhdnNCVkeHUh?=
NCI-H2122NWLiPW1OT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFjsXVZKSzVyPUKyMlI1OzJizszNMlG4V2FPT0WU
NCI-H526MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnjnTWM2OD1{Mj6zPFk2KM7:TR?=M37uSnNCVkeHUh?=
NCI-H1650MoXQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3;GWmlEPTB;MkKuO|Y1KM7:TR?=NVriRXlpW0GQR1XS
AM-38MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3XUTmlEPTB;MkKuPFY5QSEQvF2=M3TGeXNCVkeHUh?=
NCI-H2405NIrJR|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYrJR|UxRTJ|LkK1N|Mh|ryPMUnTRW5ITVJ?
M14M4jk[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\ITWM2OD1{Mz60NFg5KM7:TR?=M{TCOXNCVkeHUh?=
ES4MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlnTTWM2OD1{Mz60NlMzKM7:TR?=NXjFWINHW0GQR1XS
DJM-1MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1j5V2lEPTB;MkOuOVI{PCEQvF2=MXTTRW5ITVJ?
S-117M2rteWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHW5TXpKSzVyPUKzMlc3PTFizszNNVyzVW12W0GQR1XS
MZ2-MELMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGXze2lKSzVyPUKzMlc4PTlizszNM2\sWXNCVkeHUh?=
SK-MEL-2M1v0W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYjJR|UxRTJ|LkixN|Mh|ryPMoKyV2FPT0WU
HCC1806M1HVNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NU[5PXlbUUN3ME2yN{45PzB7IN88US=>NFjCN3RUSU6JRWK=
NMC-G1NYr2R2xYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXTJR|UxRTJ2LkKyNlYh|ryPMkWwV2FPT0WU
DK-MGMoDXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3\uc2lEPTB;MkSuNlk1KM7:TR?=M{XuTnNCVkeHUh?=
SK-N-FINHTINnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1nvRWlEPTB;MkSuN|MxOiEQvF2=NGTaS|VUSU6JRWK=
KINGS-1M3fsemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWnFbXB4UUN3ME2yOE41QDd2IN88US=>NXjGR4YzW0GQR1XS
HCC2998MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1u1TGlEPTB;MkSuOFg5PSEQvF2=MYnTRW5ITVJ?
ALL-PONIXQ[3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXrJR|UxRTJ2Lk[xPUDPxE1?MoP5V2FPT0WU
MPP-89MmfFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXPJR|UxRTJ3LkC0OVgh|ryPNVe5UGJ{W0GQR1XS
NCI-H2342M2HXS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIq4dVFKSzVyPUK1MlE6PTNizszNM4DhV3NCVkeHUh?=
TE-1NYrBcHJiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NET2cZNKSzVyPUK1MlM2PjNizszNMmHiV2FPT0WU
RH-18NHfOclJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHy0NFRKSzVyPUK1MlU6OThizszNNVPQNZpWW0GQR1XS
HT-1376NYThTYU6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWe3b4lnUUN3ME2yOU43PDZ3IN88US=>MWLTRW5ITVJ?
U-2-OSMX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4fSWGlEPTB;MkWuOlg5QCEQvF2=NYDp[Gk6W0GQR1XS
BT-549MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlKzTWM2OD1{NT65NFEyKM7:TR?=NEDPbGVUSU6JRWK=
NCI-H1755M4fkXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXPhUo5{UUN3ME2yOU46QTR3IN88US=>Mo\sV2FPT0WU
EW-13NHrtOIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3PBRWlEPTB;Mk[uNFI4PCEQvF2=Mn7kV2FPT0WU
NB13NVzhcVBLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NG\YNJBKSzVyPUK2MlA6PDlizszNNVPidZVNW0GQR1XS
NUGC-3MkjPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYLJR|UxRTJ4LkKxNFMh|ryPNXfGVm5pW0GQR1XS
GMS-10NHTERVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYLIb4hpUUN3ME2yOk4zOzV|IN88US=>MnfoV2FPT0WU
CHP-134M1H6RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXXjVGFLUUN3ME2yOk4{QDZ5IN88US=>M1zZXXNCVkeHUh?=
SW962NF3iZnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEDFOpFKSzVyPUK2MlUxOjFizszNNFGyPJlUSU6JRWK=
SNU-449MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTJ5LkC4NFMh|ryPMUTTRW5ITVJ?
HuP-T4MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFPuUpBKSzVyPUK3MlA5PzlizszNMUDTRW5ITVJ?
SW948NUPkUotIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXLmeG1VUUN3ME2yO{4yOzR2IN88US=>NHLadZlUSU6JRWK=
NCI-H226NWHWU2NtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHGzcZRKSzVyPUK3MlQ2PzhizszNNF3DO4RUSU6JRWK=
SK-PN-DWNFfEVotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEXDOoxKSzVyPUK3MlYxOTJizszNNH3nc|NUSU6JRWK=
GI-1M3z4[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHW3RoFKSzVyPUK3MlczOSEQvF2=M{LTTnNCVkeHUh?=
CAL-12TNGSxVlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{KzVGlEPTB;MkiuNVEyOiEQvF2=NYnMWWJSW0GQR1XS
YAPCNVTHTIF3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV;JR|UxRTJ6LkK1OlQh|ryPM{e5XXNCVkeHUh?=
SNU-C2BNUm5S3E5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnrLTWM2OD1{OD6yPVY1KM7:TR?=M3q1THNCVkeHUh?=
RCC10RGBM2Dofmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4\tN2lEPTB;MkiuOVQyPyEQvF2=M4qwenNCVkeHUh?=
ES7M1nvZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXHD[2dyUUN3ME2yPU4yPDZ3IN88US=>M1fpNnNCVkeHUh?=
PANC-03-27NVS1S5YyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{\jO2lEPTB;MkmuOFQ1KM7:TR?=Mkj4V2FPT0WU
ES6MonvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkfaTWM2OD1{OT64NVU4KM7:TR?=MnvQV2FPT0WU
HT-1197NED1fW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHX4dnpKSzVyPUOwMlA2QThizszNNYDlWYk1W0GQR1XS
ZR-75-30NF\Vc4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFHQPVBKSzVyPUOwMlI{QDNizszNM1HTT3NCVkeHUh?=
DBNXnQfpVvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXzHWoNwUUN3ME2zNE41QTR{IN88US=>M1naN3NCVkeHUh?=
OCI-AML2Ml7wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVe5[nkzUUN3ME2zNU4xPjlizszNNEnCVYFUSU6JRWK=
NCI-H2170NUnTbIx5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2f3SGlEPTB;M{GuPFUyPiEQvF2=NHS5OG1USU6JRWK=
IST-MES1NWqzZVNXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYPJR|UxRTN{LkK4PVch|ryPNWL6PJVqW0GQR1XS
769-PMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzFfmxDUUN3ME2zNk4{PjRzIN88US=>NHi2W21USU6JRWK=
COR-L23NUTK[nB[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVfhfmhIUUN3ME2zNk46ODd|IN88US=>M3HhR3NCVkeHUh?=
SW626MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXvJR|UxRTN|LkG3O|Yh|ryPNYTmWmZoW0GQR1XS
LU-139MljPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGj1OVZKSzVyPUOzMlY3ODVizszNNIKxO|BUSU6JRWK=
HT-144NYLQNZRYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWrJR|UxRTN|Lki2N{DPxE1?MnXkV2FPT0WU
CaR-1MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUK2W25{UUN3ME2zN{46QDJ{IN88US=>M2LmU3NCVkeHUh?=
OE33MnHNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzSS3pKSzVyPUO0MlI5PTVizszNMWLTRW5ITVJ?
COLO-800NEe3flVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUTJR|UxRTN2LkO2OFch|ryPNFP1N5ZUSU6JRWK=
NB14NVKyO|RmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MU\JR|UxRTN2LkS2PFQh|ryPNHrjVVVUSU6JRWK=
KURAMOCHINHfnTWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWXwRo1DUUN3ME2zOk4yOTl6IN88US=>Moe4V2FPT0WU
SW48NXLLSFF2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUXReYFzUUN3ME2zOk4zPDd2IN88US=>M3i0eHNCVkeHUh?=
DaoyNIjzcZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV70bFVFUUN3ME2zOk43PTN6IN88US=>MYrTRW5ITVJ?
TGBC24TKBM2nyUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1vGbmlEPTB;M{[uOlch|ryPNUKwe3R1W0GQR1XS
DU-4475MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGTKWJZKSzVyPUO2MlkxOzNizszNMn3aV2FPT0WU
SW1417NHTiVppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFL1[W9KSzVyPUO4MlA2PTJizszNNGXPT4tUSU6JRWK=
EFO-21NVThc3czT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHXTbXVKSzVyPUO4Mlk{PDlizszNMoD2V2FPT0WU
MG-63MkX4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF\sS|hKSzVyPUO5MlM1OjRizszNNHPmSI9USU6JRWK=
LC-2-adM1O0eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml3GTWM2OD1|OT61OVEzKM7:TR?=NFXYVWZUSU6JRWK=
NOMO-1NVLUfms2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIPnOm1KSzVyPUO5MlgzPzRizszNM1rYPXNCVkeHUh?=
COLO-741NGjqfFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYTqW2E4UUN3ME20NE4yOzB2IN88US=>MnvqV2FPT0WU
BxPC-3NEH3bYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIf6dZJKSzVyPUSwMlU3QDZizszNMWTTRW5ITVJ?
HSC-2MkLhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnLpTWM2OD12MD65NVE{KM7:TR?=MXTTRW5ITVJ?
UMC-11M3W0W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlXjTWM2OD12MT6yOlMh|ryPM{PhNHNCVkeHUh?=
HCC1937MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF;ON|FKSzVyPUSyMlc5PDNizszNMUjTRW5ITVJ?
Calu-6NHS0fXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mny4TWM2OD12Mz6yN|gzKM7:TR?=Mmf6V2FPT0WU
NCI-H1573MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXfJR|UxRTR|LkO0O|ch|ryPM1XzS3NCVkeHUh?=
SK-N-ASM374[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVzJR|UxRTR|Lk[wNVkh|ryPM1PXNXNCVkeHUh?=
PSN1NUPKTWppT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVHJR|UxRTR3LkK1OFgh|ryPM1fLd3NCVkeHUh?=
TE-11NYjadGJJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYLReo5SUUN3ME20OU41QDR{IN88US=>NF\5[XJUSU6JRWK=
NCI-H1155MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWPzPYxrUUN3ME20OU45QTZ5IN88US=>NIHFbVBUSU6JRWK=
KM12M{nJfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{LUeGlEPTB;NEWuPVA4PiEQvF2=M{X0fXNCVkeHUh?=
RO82-W-1MmX2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX;XUoRIUUN3ME20Ok46QDJ{IN88US=>NIHNdJNUSU6JRWK=
SW1573MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHT6cJpKSzVyPUS3MlM4OzZizszNNEnFbJVUSU6JRWK=
CAKI-1NWraclkzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHjXUIJKSzVyPUS4MlI5PDVizszNMVXTRW5ITVJ?
U-118-MGNUO4OIRJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3XIeGlEPTB;NEiuN|cxOiEQvF2=M4DNd3NCVkeHUh?=
KYSE-520Mn;qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3PVSmlEPTB;NEiuOFAyPiEQvF2=NIPOe4dUSU6JRWK=
HT55MmHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlnITWM2OD12OT6xOFc1KM7:TR?=M4f3N3NCVkeHUh?=
ChaGo-K-1NVTUcFc{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIiyOGpKSzVyPUS5MlQ4QTNizszNNVG0[5RWW0GQR1XS
IA-LMMV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFTveYVKSzVyPUW0MlY{OjJizszNM1PXOnNCVkeHUh?=
UACC-62MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWD4OIJsUUN3ME21OU4yODR4IN88US=>NWnLVW1yW0GQR1XS
MKN7NWq5[VJmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1S3TmlEPTB;NU[uNFI5PSEQvF2=M2C3PHNCVkeHUh?=
HPAF-IINFrpb5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH7ye3RKSzVyPUW2MlQxPzNizszNMYLTRW5ITVJ?
NTERA-S-cl-D1NVyzSoZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGrjd5ZKSzVyPUW3Mlc4QCEQvF2=NHHCNG5USU6JRWK=
FTC-133NGfi[IdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVHJR|UxRTV6LkC5Olkh|ryPMl;lV2FPT0WU
MHH-ES-1NG[1RYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NY\QW|dFUUN3ME21PE41QDF2IN88US=>NGiyc5JUSU6JRWK=
JVM-2NGTBc|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWjFVoo6UUN3ME21PE46PTB4IN88US=>NHn4RXVUSU6JRWK=
TCCSUPM3fI[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWS3U5FUUUN3ME21PU42Ojd7IN88US=>NFHKeYpUSU6JRWK=
COLO-824Mm\yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NY\ZVINIUUN3ME22NE4xPzF7IN88US=>MkTCV2FPT0WU
647-VNIf5WGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkjETWM2OD14MD6xN|Q4KM7:TR?=NYTRe4wzW0GQR1XS
HD-MY-ZMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWrYVFl2UUN3ME22NE42Ojl2IN88US=>MnvEV2FPT0WU
LS-411NMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkPvTWM2OD14MT6zPVA{KM7:TR?=MYLTRW5ITVJ?
NCI-H596M{TKdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{TJO2lEPTB;NkKuO|Q6PiEQvF2=NY\OPHRZW0GQR1XS
C-33-AMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHvi[I1KSzVyPU[0MlA6PTdizszNMUHTRW5ITVJ?
BHYM1zVPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1fwS2lEPTB;NkSuNVI1PSEQvF2=MWjTRW5ITVJ?
KGNNXX2NpJ7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUDJR|UxRTZ2LkW1NVQh|ryPNVrxNnJNW0GQR1XS
NCI-H1092M2KydWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTtOHlQUUN3ME22OU4xODl3IN88US=>NUn4S3JXW0GQR1XS
MZ1-PCMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlHuTWM2OD14NT61OlQ6KM7:TR?=MXjTRW5ITVJ?
LB831-BLCM{\3[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFK1[GxKSzVyPU[1Mlg1QDFizszNM2rpTHNCVkeHUh?=
SW620MmXoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlPGTWM2OD14Nj6yNFM6KM7:TR?=MXnTRW5ITVJ?
HuO-3N1Ml73S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGXERopKSzVyPU[4MlMzOzhizszNNYm0TGgyW0GQR1XS
SK-HEP-1NUTFcZpDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYTYN3E6UUN3ME22PU46PDh4IN88US=>NUjMZmlmW0GQR1XS
LCLC-103HMkXyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmTqTWM2OD15MD62O|A2KM7:TR?=MXPTRW5ITVJ?
KYSE-70M4DZNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnLCTWM2OD15MD63PFM2KM7:TR?=M{\pPXNCVkeHUh?=
MewoMUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX\JR|UxRTdzLkWwOUDPxE1?M33teXNCVkeHUh?=
COLO-668MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHi1UFFKSzVyPUexMlg1PTFizszNNEjE[lVUSU6JRWK=
NCI-H522M3\OOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\CTWlEPTB;N{KuN|QyOyEQvF2=Mk\vV2FPT0WU
NCI-H1437NFfKW2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUC5c3RMUUN3ME23OE41ODR6IN88US=>NUjNVmZRW0GQR1XS
U-266NYLJeXlVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2XKUGlEPTB;N{WuOFUyPiEQvF2=MWnTRW5ITVJ?
MC116MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWHJR|UxRTd3LkW3NFgh|ryPNHPtZZRUSU6JRWK=
PANC-10-05M3vtbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFm1SpdKSzVyPUe3MlQzPDNizszNM1\RbHNCVkeHUh?=
KYSE-180MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWrlSmwzUUN3ME23O{42PDV2IN88US=>MmLtV2FPT0WU
JARNICz[m9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVe3OIR4UUN3ME23PU4xPTR4IN88US=>M1q2V3NCVkeHUh?=
CAL-62NHzyemRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{HKOGlEPTB;OECuNFk2KM7:TR?=M4nMdHNCVkeHUh?=
A3-KAWMnv1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWK4c3VoUUN3ME24NE4zOTV2IN88US=>MWnTRW5ITVJ?
PANC-08-13MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHniPZZKSzVyPUixMlE4PjhizszNNXHZXYdpW0GQR1XS
HSC-3M37UWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTh|LkOwO|Eh|ryPMWnTRW5ITVJ?
HTC-C3NGLNW3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWXJR|UxRTh|LkS3NFIh|ryPMU\TRW5ITVJ?
KY821M2Xt[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkP0TWM2OD16ND6wPFkzKM7:TR?=NH\2ToRUSU6JRWK=
DoTc2-4510Ml7qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3HRfWlEPTB;OESuNlE5PSEQvF2=MUDTRW5ITVJ?
NCI-H1581MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHQTnBJUUN3ME24OU41PjRzIN88US=>M4DMOnNCVkeHUh?=
KARPAS-299MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIfGR4RKSzVyPUi2MlE6PzdizszNNH31cnNUSU6JRWK=
IST-MEL1M1\Xemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFHMTVFKSzVyPUi2Mlg5PzJizszNNH;qNmlUSU6JRWK=
KP-N-YSNXvFWWg2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4iyWWlEPTB;OEmuPVAzQCEQvF2=MlXuV2FPT0WU
KYSE-410MmfPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4nmcGlEPTB;OUGuOFA1OiEQvF2=NFzrUoJUSU6JRWK=
TE-10Ml22S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUXSNZJJUUN3ME25NU42PjFzIN88US=>MXPTRW5ITVJ?
SK-MEL-1M3zORmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVr3cHFjUUN3ME25Nk46OTB4IN88US=>NEnXU3FUSU6JRWK=
COLO-792MlvUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGXwdWhKSzVyPUm1MlI2PjRizszNM3vQZXNCVkeHUh?=
SCHMnLiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWTJR|UxRTl4LkO4O|ch|ryPMX7TRW5ITVJ?
NCI-H1792NGnYTWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M17PbGlEPTB;OU[uPFk6OiEQvF2=NVmyTGlLW0GQR1XS
NCI-H2029M33reGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX7oWJFmUUN3ME25Ok46PTZ4IN88US=>NH;EZXlUSU6JRWK=
SW684M3PrfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4DZ[mlEPTB;OUiuOlY2PCEQvF2=NULvSpFtW0GQR1XS
NCI-H209M2rCZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4XOR2lEPTB;MUCwMlEzOSEQvF2=MlTuV2FPT0WU
HLEMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkSxTWM2OD1zMEWuNlgzKM7:TR?=NImzPGlUSU6JRWK=
GOTOMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NETqclJKSzVyPUGwO{44PzdizszNMYXTRW5ITVJ?
NCI-H1793M1XvTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlzqTWM2OD1zMEmuNlgh|ryPNH:wcZpUSU6JRWK=
D-392MGNFj3U2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUXTWIFwUUN3ME2xNVcvOzl6IN88US=>MX3TRW5ITVJ?
SW1990MoizS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVXJR|UxRTF{MD65OVEh|ryPM{nmSXNCVkeHUh?=
ML-2MlnES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIf0dHdKSzVyPUGyNU43PzZizszNNUfUb4hSW0GQR1XS
NCI-H2452NVPCUVl7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTF{Mj6yNUDPxE1?NFPZXotUSU6JRWK=
SK-MEL-30MlvqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoHjTWM2OD1zMkOuNlQ1KM7:TR?=M4XCdnNCVkeHUh?=
SN12CNUPidm52T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYLGenk6UUN3ME2xNlQvOTd4IN88US=>NYqycGZpW0GQR1XS
NCI-H1770MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYLJR|UxRTF{NT61NVQh|ryPMWPTRW5ITVJ?
SF268NWTaWoR{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGD6[3BKSzVyPUGyOk4yPThizszNNVrwUYJJW0GQR1XS
BALL-1MnPTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUnJR|UxRTF{Nj6yN{DPxE1?MnfHV2FPT0WU
COLO-679M4O1[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYf6SFJmUUN3ME2xNlYvPzV|IN88US=>NEnmNmFUSU6JRWK=
A2780MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV7JR|UxRTF{OD65PFgh|ryPNVTTdmp5W0GQR1XS
NCI-H1651M1zh[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWm3TnFjUUN3ME2xN|EvOjR|IN88US=>M1vhTnNCVkeHUh?=
NCI-H2087M{\GR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGTzRm5KSzVyPUGzNU41QDNizszNNHvDWWJUSU6JRWK=
U-87-MGMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4jYXWlEPTB;MUOzMlYxPCEQvF2=MVXTRW5ITVJ?
LB2518-MELMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUntRnlnUUN3ME2xN|UvQTl|IN88US=>NVXMXJZzW0GQR1XS
HCT-116MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUfJR|UxRTF|Nz6yNVch|ryPM1z4SHNCVkeHUh?=
Ca9-22MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVKySXBiUUN3ME2xN|kvQDN|IN88US=>MYnTRW5ITVJ?
COR-L88NFnnOJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3vWZ2lEPTB;MUSyMlE1KM7:TR?=M4nHNHNCVkeHUh?=
CP50-MEL-BNVjmVHZGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mlq5TWM2OD1zNESuOVAyKM7:TR?=NGntXJlUSU6JRWK=
OVCAR-8NXLTZ2RKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYHVV4RKUUN3ME2xOFUvPjN4IN88US=>NWexT2luW0GQR1XS
SK-MEL-3M17oNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTF2Nz64O|gh|ryPMUHTRW5ITVJ?
GT3TKBM33CbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVLkXnQ5UUN3ME2xOFkvQTJ6IN88US=>MXzTRW5ITVJ?
KYSE-450NGrWOmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEOwc5RKSzVyPUG1NU42OzlizszNNHW4fmxUSU6JRWK=
CAPAN-1MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3f2VmlEPTB;MUWzMlA3PCEQvF2=MULTRW5ITVJ?
BENMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1L3UWlEPTB;MUWzMlkzQCEQvF2=MoraV2FPT0WU
NCI-H1304NVjMTJR6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTF3ND62PVQh|ryPMnLUV2FPT0WU
KU812MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXziXIZQUUN3ME2xOVgvPjd2IN88US=>MoH0V2FPT0WU
Capan-2NWK2eIFzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoXwTWM2OD1zNkCuOVU{KM7:TR?=MWPTRW5ITVJ?
A673NXfLZlg{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnvuTWM2OD1zNkGuO|A2KM7:TR?=MlLnV2FPT0WU
SASMYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4\EUmlEPTB;MU[yMlY4QCEQvF2=NWj3WFR2W0GQR1XS
NYMnqxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkHXTWM2OD1zNkWuN|E1KM7:TR?=NWDWU3p4W0GQR1XS
HCE-4Ml7hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3LnS2lEPTB;MU[2Mlg1PSEQvF2=NHvWXVJUSU6JRWK=
MDA-MB-231MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2PTOGlEPTB;MUe3MlUxOyEQvF2=NH\uTJhUSU6JRWK=
no-10NVvxTm5OT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEHMSXRKSzVyPUG3PE4yOzRizszNMYnTRW5ITVJ?
MZ7-melNVfvU45qT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV\JR|UxRTF5OD60Olch|ryPMUnTRW5ITVJ?
NCI-H82NHPpTnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV\aR|RbUUN3ME2xPFAvOTZ3IN88US=>NYrwbGRjW0GQR1XS
CAL-72NFqxXo1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkTWTWM2OD1zOEWuNFU1KM7:TR?=MofoV2FPT0WU
NCI-SNU-5M4fmTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWGwbolvUUN3ME2xPFYvQDRizszNNVjTd5hKW0GQR1XS
OVCAR-4M{TiRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTF6OD6zN|Mh|ryPNEHvWZpUSU6JRWK=
SCC-9NH3CcXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVTNU4JDUUN3ME2xPVEh|ryPM2rw[3NCVkeHUh?=
KYSE-150MkHSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4fjSGlEPTB;MUmxMlg5QCEQvF2=MlzDV2FPT0WU
HT-29NI\jbGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXaZZNKSzVyPUKwNU4zOTJizszNMkDrV2FPT0WU
COLO-678NUXRRm5RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGDOOI1KSzVyPUKwNU41PSEQvF2=Mk\RV2FPT0WU
NCI-H650NULRfm1yT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGrJXnVKSzVyPUKwNk4yODNizszNM2DNVXNCVkeHUh?=
HuCCT1NFj0bGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHLuPYhKSzVyPUKwOE4zODhizszNNECwfGVUSU6JRWK=
SW1116NWHLXVJRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXzJR|UxRTJyNz6wO|ch|ryPM3e0XnNCVkeHUh?=
DBTRG-05MGNXPVeGR5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTJyNz65NFkh|ryPM2\NfnNCVkeHUh?=
SW982MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{PDbWlEPTB;MkC3Mlk1QCEQvF2=NXe1TmNwW0GQR1XS
RCM-1NXXjTVBtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmGzTWM2OD1{MUSuO|YzKM7:TR?=NFvVUXFUSU6JRWK=
COLO-320-HSRNYixUohXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWrx[VdmUUN3ME2yNVYvOTJ3IN88US=>NEDKO2FUSU6JRWK=
KNS-42NF71eXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWTJR|UxRTJzNj61O|Qh|ryPNULRXFY4W0GQR1XS
C2BBe1NHrHOZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MULJR|UxRTJ|MT65NFUh|ryPNXzXZ3JqW0GQR1XS
CCRF-CEMNXrP[3dVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWjJR|UxRTJ2Mz63PVUh|ryPNWPnbYNyW0GQR1XS
SH-4M2jsVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYfJR|UxRTJ2Nj6wPUDPxE1?NFHI[IdUSU6JRWK=
LS-1034MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV\JR|UxRTJ2Nj6yOlYh|ryPMlvaV2FPT0WU
NCI-H2347M{\MXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF7aeldKSzVyPUK0O{44OTNizszNNUiybWwzW0GQR1XS
RPMI-8866M3G2T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MorWTWM2OD1{NEmuNlch|ryPM1\oeXNCVkeHUh?=
GAKMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3q3bmlEPTB;MkWzMlAxOiEQvF2=NXWydpYxW0GQR1XS
NB6NX7p[FVXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVvJR|UxRTJ5MD6xJO69VQ>?MV3TRW5ITVJ?
COLO-680NMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnvrTWM2OD1{N{KuOVI4KM7:TR?=NUDoVJB1W0GQR1XS
RERF-LC-MSMmDqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWW1bXQzUUN3ME2yO|YvODB5IN88US=>NY\DS29RW0GQR1XS
TGBC11TKBNW[0b|ZzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{\0[2lEPTB;Mke4MlE4QCEQvF2=MWLTRW5ITVJ?
C8166MkDnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XWc2lEPTB;Mke4MlUxPiEQvF2=M2nnR3NCVkeHUh?=
HDLM-2NGPJXWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF3SUFBKSzVyPUK5OE41ODlizszNMWrTRW5ITVJ?
IGR-1M3LMcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoX4TWM2OD1{OUWuOlU6KM7:TR?=NFjMUXhUSU6JRWK=
FADUNELyd3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4\5cmlEPTB;Mkm3MlUyKM7:TR?=NYHVOpN6W0GQR1XS
L-428M{HsT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVfJR|UxRTJ7Nz62NVYh|ryPNWG4UlVsW0GQR1XS
LU-65NWXIbY9MT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIi0WoRKSzVyPUOwOE4{OiEQvF2=NXW4VmhuW0GQR1XS
HELNHzQSJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYHJR|UxRTNyOT65PFMh|ryPNF;vTJlUSU6JRWK=
NCI-H810MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlTQTWM2OD1|MUCuOVch|ryPMni4V2FPT0WU
C3ANVfRN|R1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmjXTWM2OD1|MUGuPFAzKM7:TR?=MYXTRW5ITVJ?
NCI-H630MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEHhenRKSzVyPUOzNk4zQTRizszNMoX0V2FPT0WU
KP-N-YNM3HvUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHxTWM2OD1|NEGuNVI{KM7:TR?=M3nFOXNCVkeHUh?=
MOLT-13NI\DbpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4myfGlEPTB;M{SyMlMzPiEQvF2=NISxOZdUSU6JRWK=
NCI-H1993M1zJNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUnyfYhPUUN3ME2zOFIvOzZ3IN88US=>M2HEU3NCVkeHUh?=
BE-13M37YWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHfDTWZKSzVyPUO0OE4yPjdizszNMlHOV2FPT0WU
IST-SL1M2nybGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mlf0TWM2OD1|NEeuOFAyKM7:TR?=NIrJSZhUSU6JRWK=
TE-9MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV7RfG9oUUN3ME2zOlMvPTh7IN88US=>NYi4UGhsW0GQR1XS
LU-135NHn1WYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{LDV2lEPTB;M{[3MlA{PSEQvF2=NFLJ[|lUSU6JRWK=
T84NHzCXIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkHRTWM2OD1|N{SuO|EzKM7:TR?=NE\0RoZUSU6JRWK=
K-562NGTWNldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYjjfXN3UUN3ME2zPFMvOzZizszNNFXqRZlUSU6JRWK=
SBC-5MkTVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV;6[nJtUUN3ME2zPFYvQTh3IN88US=>NF\x[2tUSU6JRWK=
NB17M{e5bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXHOOJhCUUN3ME2zPVIvPTl4IN88US=>MXPTRW5ITVJ?
NCI-H2052Ml7JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3TjcWlEPTB;M{m4MlQ4OiEQvF2=MYnTRW5ITVJ?
HCC38NGXqOnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX:5[GR7UUN3ME20NFEvPTl|IN88US=>M4TMc3NCVkeHUh?=
NCI-H69MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUH5blFJUUN3ME20OFEvODh|IN88US=>MW\TRW5ITVJ?

... Click to View More Cell Line Experimental Data

In vivo MK-2206 shows 60% TGI and inhibits more than 70 % of phospho-Akt1/2 (T308 and S473) in A2780 ovarian cancer xenografts at a dose of 240 mg/kg. [1] MK-2206 exhibits significant antitumor activity in NCI-H292 xenograft in combination with erlotinib or lapatinib. [2]
Features The first allosteric small molecule inhibitor of Akt to enter clinical development.

Protocol(Only for Reference)

Kinase Assay: [4]

Akt kinases assay Akt kinases are assayed by a GSK-derived biotinylated peptide substrate. The extent of peptide phosphorylation is determined by Homogeneous Time Resolved Fluorescence (HTRF) using a lanthanide chelate (Lance)-coupled monoclonal antibody specific for the phosphopeptide in combination with a streptavidin-linked allophycocyanin (SA-APC) fluorophore which will bind to the biotin moiety on the peptide. When the Lance and APC are in proximity, a non-radiative energy transfer takes place from the Lance to the APC, followed by emission of light from APC at 655 nm. Working Solution: 100X protease inhibitor cocktail (PIC): 1mg/mL benzamidine, 0.5 mg/mL pepstatin, 0.5 mg/mL leupeptin, 0.5 mg/mL aprotinin; 10X assay buffer: 500 mM HEPES, pH7.5, 1% PEG, 16.6 mM EDTA, 1 mM EGTA, 1% BSA, 20 mM 9-glycerol phosphate; Quench buffer 50 mM HEPES pH 7.3, 16.6 mM EDTA, 0.1% BSA, 0.1% Triton X-100, 0.17 nM labeled monoclonal antibody, 0.0067 mg/mL SA-APC; ATP/MgCl2 working solution: 1X Assay buffer, 1 mM DTT, 1X PIC, 5% glycerol, active Akt; Peptide working solution: 1X Assay buffer, 1 mM DTT, 1X PIC, 5% glycerol, 2 TM GSK biotinylated peptide. The reaction is assembled by adding 16 µL of ATP/MgCl2 working solution to the appropriate wells. MK-2206 or vehicle (1.0 µL) is added followed by 10 µL of peptide working solution. The reaction is started by adding 13 μL of the enzyme working solution and mixing. The reaction is allowed to proceed for 50 min and then stopped by the addition of 60 µL HTRF quench buffer. The stopped reactions are incubated at room temperature for at least 30 min and then read in the instrument.

Cell Assay: [2]

Cell lines A431, HCC827, NCI-H292, NCI-H358, NCI-H23, NCI-H1299, Calu-6 and NCI-H460 cells
Concentrations 0, 0.3, 1 and 3 μM
Incubation Time 72 or 96 hours
Method MK-2206 is dissolved in DMSO as a stock solution and diluted by culture media before use. Cells are seeded at a density of 2-3 × 103 in 96-well plates and incubated for 24 hours. Then MK-2206 (0, 0.3, 1 and 3 μM) is added to the cells. Cell proliferation is determined after 72 or 96 hours.

Animal Study: [2]

Animal Models SK-OV-3, NCI-H292, HCC70, PC-3, and NCI-H460 models in male CD1-nude mice
Formulation Formulated in 30% Captisol
Dosages 120 mg/kg
Administration Orally administered

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Yan L, AACR Annual Meeting 2009: Abstract Number: DDT01-1.

[2] Hirai H, et al. Mol Cancer Therapy, 2010, 9(7), 1956-1967.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT01802320 Active, not recruiting Colon Mucinous Adenocarcinoma|Colon Signet Ring Cell Adenocarcinoma|Rectal Mucinous Adenocarcinoma|Rectal Signet Ring Cell Adenocarcinoma|Recurrent  ...more Colon Mucinous Adenocarcinoma|Colon Signet Ring Cell Adenocarcinoma|Rectal Mucinous Adenocarcinoma|Rectal Signet Ring Cell Adenocarcinoma|Recurrent Colon Carcinoma|Recurrent Rectal Carcinoma|Stage IIIA Colon Cancer|Stage IIIA Rectal Cancer|Stage IIIB Colon Cancer|Stage IIIB Rectal Cancer|Stage IIIC Colon Cancer|Stage IIIC Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer National Cancer Institute (NCI) March 2013 Phase 2
NCT01783171 Recruiting Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unresectable Pancreatic Carcinoma National Cancer Institute (NCI) January 2013 Phase 1
NCT01776008 Active, not recruiting Estrogen Receptor Positive|HER2/Neu Negative|Recurrent Breast Carcinoma|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|St  ...more Estrogen Receptor Positive|HER2/Neu Negative|Recurrent Breast Carcinoma|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer National Cancer Institute (NCI) January 2013 Phase 2
NCT01859182 Withdrawn Adenocarcinoma of the Gallbladder|Adenocarcinoma With Squamous Metaplasia of the Gallbladder|Adult Primary Cholangiocellular Carcinoma|Advanced Adu  ...more Adenocarcinoma of the Gallbladder|Adenocarcinoma With Squamous Metaplasia of the Gallbladder|Adult Primary Cholangiocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Extrahepatic Bile Duct|Localized Unresectable Adult Primary Liver Cancer|Metastatic Extrahepatic Bile Duct Cancer|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile Duct Cancer|Stage II Gallbladder Cancer|Stage IIIA Gallbladder Cancer|Stage IIIB Gallbladder Cancer|Stage IVA Gallbladder Cancer|Stage IVB Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer National Cancer Institute (NCI) January 2013 Phase 2
NCT01705340 Terminated Adenocarcinoma of the Gastroesophageal Junction|HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Recurrent Esophageal Cancer|  ...more Adenocarcinoma of the Gastroesophageal Junction|HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Recurrent Esophageal Cancer|Recurrent Gastric Cancer|Stage IIIC Breast Cancer|Stage IIIC Esophageal Cancer|Stage IIIC Gastric Cancer|Stage IV Breast Cancer|Stage IV Esophageal Cancer|Stage IV Gastric Cancer National Cancer Institute (NCI) September 2012 Phase 1

view more

Chemical Information

Download MK-2206 2HCl SDF
Molecular Weight (MW) 480.39
Formula

C25H21N5O.2HCl

CAS No. 1032350-13-2
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 14 mg/mL (29.14 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 15% Captisol 17 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Akt Products

  • Afuresertib (GSK2110183)

    Afuresertib (GSK2110183) is a potent, orally bioavailable Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2.

  • AT13148

    AT13148 is an oral, ATP-competitive, multi-AGC kinase inhibitor with IC50 of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively. Phase 1.

  • SC79

    SC79 is a brain-penetrable Akt phosphorylation activator and an inhibitor of Akt-PH domain translocation.

  • AZD5363

    AZD5363 potently inhibits all isoforms of Akt(Akt1/Akt2/Akt3) with IC50 of 3 nM/8 nM/8 nM in cell-free assays, similar to P70S6K/PKA and lower activity towards ROCK1/2. Phase 2.

    Features:Moderate preclinical tolerability, and PD characteristics of an AKT inhibitor. Distinct profile from other AKT inhibitors in clinical development.

  • Ipatasertib (GDC-0068)

    Ipatasertib (GDC-0068) is a highly selective pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM in cell-free assays, 620-fold selectivity over PKA. Phase 2.

  • GSK690693

    GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM in cell-free assays, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. Phase 1.

  • Perifosine (KRX-0401)

    Perifosine (KRX-0401) is a novel Akt inhibitor with IC50 of 4.7 μM in MM.1S cells, targets pleckstrin homology domain of Akt. Phase 3.

  • A-674563

    A-674563 is an Akt1 inhibitor with Ki of 11 nM in cell-free assays, modest potent to PKA and >30-fold selective for Akt1 over PKC.

    Features:Orally bioavailable compound (achieved by replacing indole of A-443654 with phenyl moiety) and somewhat less selective for Akt over PKA than A-443654.

  • Triciribine

    Triciribine is a DNA synthesis inhibitor, also inhibits Akt in PC3 cell line and HIV-1 in CEM-SS, H9, H9IIIB, U1 cells with IC50 of 130 nM and 20 nM, respectively; does not inhibit PI3K/PDK1; 5000-fold less active in cells lacking adenosine kinase. Phase 1/2.

  • Honokiol

    Honokiol is the active principle of magnolia extract that inhibits Akt-phosphorylation and promotes ERK1/2 phosphorylation. Phase 3.

Recently Viewed Items

Tags: buy MK-2206 2HCl | MK-2206 2HCl supplier | purchase MK-2206 2HCl | MK-2206 2HCl cost | MK-2206 2HCl manufacturer | order MK-2206 2HCl | MK-2206 2HCl distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us